EUVIMED · CrossrefZeitschrift
Cancer Research Communications
ISSN 2767-9764 · American Association for Cancer Research (AACR)
Neueste Artikel
Primary mediastinal large B-cell lymphoma genomic profiling demonstrates thymic B-cell identity and frequent aberrant somatic hypermutation
Social vulnerability index associates with chronic lymphocytic leukemia survival rates in the Detroit tri-county area
Irradiation induces an epigenetically plastic CD44low persister cell population associated with tumor regrowth in colorectal cancer
Distinguishing Features of Radiation-Induced from Sporadic Thyroid Cancers after the Chornobyl Nuclear Power Plant Accident
Combination Therapy with AKT and MEK Inhibitors is Effective in Patient-Derived Models of Adrenocortical Carcinoma
A Phase 1 Trial of Low-dose Gemcitabine Combined with ATR Inhibitor Elimusertib for Advanced Solid Tumors
A Practical Guide to Choosing Multiple-Comparison Tests for Efficacy Analysis in Small-Sample Patient-Derived Xenograft Studies
MicroRNA Expression in Macrophages Regulates Antibody-Dependent Effector Function and B-cell Lymphoma Therapy
Comparative Analysis of Ovarian Cancer Tumor-Infiltrating T Cells with Those in Melanoma and before and after PD-1 Blockade
Cancer Cell CD73 Loss Promotes a Dual Inflammatory and Immunosuppressive Microenvironment in Endometrial Carcinoma
The Use of TF-Ag-α to Selectively Capture Tumor-Derived Extracellular Vesicles and Enhance the Predictive Performance of Extracellular Vesicle PD-L1 for Response to Immune Checkpoint Inhibitors
Androgen-Mediated T-cell Suppression Drives Sex Bias in Head and Neck Squamous Cell Carcinoma
Prognostic Modeling Integrating RAS and SMAD4 Status in Patients with BRAF Wild-Type, Microsatellite-Stable Metastatic Colorectal Cancer
Biomarker Modulation by Aspirin and Metformin for Colorectal Cancer Prevention: Results from the ASAMET Randomized Phase II Trial
Paxalisib with Trastuzumab for HER2-Positive Metastatic Breast Cancer with Active Brain Metastases: A Phase II Trial with Integrated Plasma and CSF ctDNA Analyses
MCL1 may not mediate chemoresistance in cancer cells
Mechanisms of pregnancy-associated triple negative breast cancer risk: insights from spatial omics
A First-in-Human, Phase I Trial of MK-6598, an Inhibitor of the Immune Checkpoint IL4I1, With or Without Pembrolizumab for Advanced Solid Tumors
Anti–PD-L1 glycoengineering enhances tumor killing through coordinated interactions between PD-L1⁺ DCs and CD16A⁺ cytotoxic lymphocytes
Elucidating the Gene Expression Signature of Rosai–Dorfman Disease: A Study from the Atlas of Blood Cancer Genomes Initiative
ERX-208 Induces Endoplasmic Reticulum Stress and Suppresses DNA Damage Repair to Enhance Chemotherapy Sensitivity
Targeting PRMT5 Inhibitor–Induced Adaptation in Pancreatic Cancer with the RBM39 Degrader Indisulam
Improving Long-Read Somatic Structural Variant Calling with Pangenome and De Novo Personal Genome Assembly
Phase I Study of Oncolytic Virus VV1 as Monotherapy or in Combination with Avelumab in Patients with Relapsed Refractory Solid Tumors
Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non–Small Cell Lung Cancer: Insights From the EVOKE-01 Study
Acquisition of Resistance to RAS Inhibition Is Associated with the Upregulation of Macropinocytosis through Both PI3K-Dependent and -Independent Signaling
Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase IIa PLANETTE Study
ATR and PKMYT1 Inhibition Resensitizes a Subset of TNBC Patient-Derived Models to Carboplatin, Inducing Mitotic Catastrophe
Integrated Single-Cell Whole-Genome Sequencing and Spatial Transcriptomics Reveal Intratumoral Heterogeneity in Ovarian Cancer
Predominant Merkel Cell Polyomavirus DNA Detection in Essential Thrombocythemia within Myeloproliferative Neoplasms
EUVIMED